Invesaro

Stocks Health care LGVN

NASDAQ · Health care

Longeveron Inc. (LGVN)

Longeveron Inc. brought in $1.2M of revenue over the twelve months to June 30, 2026, down 42.7% from a year earlier. It posted a net loss of $23.5M. In fiscal 2025 capital spending exceeded operating cash flow by $18.9M. At June 30, 2026 it held $10.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Price
$2.81
-3.44% on the day · September 25, 2026
52-week range $2.30 to $12.30
Market cap
$89.6M
Revenue (last 12 months)
$1.2M
-42.7% year on year
Net margin
-1,977.6%

What Longeveron Inc. does

Longeveron Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LGVN.

Revenue and profit by year

Revenue
FY21: $5.6M $5.6M FY21FY21: $1.3M $1.3M FY21FY22: $1.2M $1.2M FY22FY23: $709K $709K FY23FY24: $2.4M $2.4M FY24FY25: $1.2M $1.2M FY25
Net income
FY21: -$3.7M -$3.7M FY21FY21: -$17M -$17M FY21FY22: -$18.8M -$18.8M FY22FY23: -$21.4M -$21.4M FY23FY24: -$16M -$16M FY24FY25: -$22.7M -$22.7M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$1.2M-$23.3M-$22.7M-$1.29-$18.9M
2024$2.4M-$16.5M-$16M-$2.62-$14.5M
2023$709K-$21M-$21.4M-$10.22-$19.3M
2022$1.2M-$18M-$18.8M-$9.02-$14.5M
2021$1.3M-$17.5M-$17M-$9.02-$10M
2021$5.6M-$3.8M-$3.7M-$2.30-$2.5M
Next report expected around December 31, 2026.

Estimated from its filing rhythm: about 141 days after its last report of August 12, 2026, its usual gap. Not a date the company has announced. See the report calendar

Where LGVN ranks in Health care

Revenue$1.2M
#563 of 646 in Health care · Bottom 13%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Longeveron Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 23, 2026
  2. September 14, 2026
  3. September 10, 2026
  4. August 24, 2026
  5. August 19, 2026
  6. August 13, 2026
  7. August 12, 2026
  8. August 12, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 9.2% to $287K versus the same quarter last year; diluted EPS -$0.19 versus -$0.33.
  9. August 10, 2026
  10. July 29, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 25, 2026. Insider transactions on SEC

Insider trades

What the people running Longeveron Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 9 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 19, 2026 Blass DevinCTO & SVP of CMC Received as pay 286,000 - - Form 4
August 19, 2026 Cann Leah RushDirector Received as pay 36,000 - - Form 4
August 19, 2026 Desai Arjun JJDirector Received as pay 36,000 - - Form 4
August 19, 2026 Ungaro UrsulaDirector Received as pay 36,000 - - Form 4
August 19, 2026 Paletta George A. Jr.Director Received as pay 36,000 - - Form 4
August 19, 2026 Soffer RockDirector Received as pay 36,000 - - Form 4
August 19, 2026 Hajjar Roger JosephDirector Received as pay 36,000 - - Form 4
August 19, 2026 Lehr Paul TGeneral Counsel, Secretary Received as pay 286,000 - - Form 4
August 17, 2026 Jhaveri Nirav S.Chief Financial Officer Received as pay 300,000 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns LGVN

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Joshua M. Hare, M.D.13D, may seek influence 25.7% 1,084,888 April 15, 2024
Mitchell P. Kopin13G, passive with 2 related filers 9% 2,941,180 August 13, 2026
Logos Global Management LP13G, passive with 5 related filers 6.3% 192,308 September 10, 2026
Janus Henderson Group PLC13G, passive 5.9% 1,291,331 May 15, 2026
Integrated Core Strategies (US) LLC13G, passive with 3 related filers 5.2% 1,553,642 August 10, 2026

Latest filings below 5%: Lincoln Alternative Strategies LLC 0% (February 10, 2026); Armistice Capital, LLC 4.99% (November 14, 2024).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

9 insiders reported holding 2,423,192 shares in total, about $6.8M at the last price.

HolderSharesAs of
Lehr Paul TGeneral Counsel, Secretary 861,423 August 19, 2026
Blass DevinCTO & SVP of CMC 711,735 August 19, 2026
Jhaveri Nirav S.Chief Financial Officer 300,000 August 17, 2026
Soffer RockDirector 262,034 August 19, 2026
Ungaro UrsulaDirector 77,000 August 19, 2026
Paletta George A. Jr.Director 70,000 August 19, 2026
Hajjar Roger JosephDirector 69,000 August 19, 2026
Desai Arjun JJDirector 36,000 August 19, 2026
Cann Leah RushDirector 36,000 August 19, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about LGVN

What does Longeveron Inc. do?

Longeveron Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker LGVN.

Is Longeveron Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $23.5M on revenue of $1.2M.

How much revenue does Longeveron Inc. make?

Over the twelve months to June 30, 2026 Longeveron Inc. reported revenue of $1.2M. That is 42.7% less than a year earlier.

When did Longeveron Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 23, 2026.

Similar companies

Compare LGVN with

Compare LGVN with any company

Follow LGVN

Get an email when Longeveron Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow LGVN: get an email when it files

Where the numbers come from

Financial figures are the values Longeveron Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.